GlassScriptPhysician profile
Grace C Berardini
NPI 1457825093
$5,573.34
in general payments reported to CMS, 2019-2025
25 companies · $1,763 in 2025
The $1,763 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,214 · 2023: $967 · 2024: $1,630 · 2025: $1,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,359.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $678.00 | 2022-2025 | Sotyktu |
| Abbvie INC. | $568.48 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $417.04 | 2022-2025 | |
| Amgen INC. | $413.57 | 2022-2025 | Otezla, Otezla, Enbrel |
| Incyte Corporation | $407.96 | 2022-2025 | Opzelura |
| Genzyme Corporation | $401.75 | 2022-2025 | |
| Ucb, INC. | $372.41 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $362.24 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $322.39 | 2022-2025 | Dupixent |
| Pfizer INC. | $244.38 | 2022-2025 | |
| Leo Pharma INC. | $234.42 | 2022-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $209.62 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $204.14 | 2022-2025 | Nemluvio, Aklief, Oracea |
| Sun Pharmaceutical Industries INC. | $151.66 | 2022-2025 | Absorica Ld, Winlevi |
| Janssen Biotech, INC. | $144.68 | 2022-2023 | Simponi Aria, Remicade, Stelara |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $116.85 | 2025 | Sofdra |
| Dermavant Sciences, INC. | $114.30 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.86 | 2025 | Cabtreo, Jublia, Siliq |
| Almirall LLC | $42.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.52 | 2023 | Spevigo |
| Organon LLC | $24.04 | 2025 | |
| Epi Health, LLC | $20.84 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $20.45 | 2025 | Fraxel |
| Medimetriks Pharmaceuticals, INC. | $16.93 | 2025 | |
| Journey Medical Corporation | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Berardini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.